Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 23, 2016 - Issue 4
Submit an article Journal homepage
510
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Burden of Wet Age-Related Macular Degeneration and Its Economic Implications in Singapore in the Year 2030

Nakul SaxenaDepartment of Health Services and Outcomes Research, National Healthcare Group, SingaporeCorrespondence[email protected] [email protected]
,
Pradeep Paul GeorgeDepartment of Health Services and Outcomes Research, National Healthcare Group, Singapore
,
Heng Bee HoonDepartment of Health Services and Outcomes Research, National Healthcare Group, Singapore
,
Lim Tock HanDepartment of Ophthalmology, Tan Tock Seng Hospital, Singapore
&
Yong Shao OnnDepartment of Ophthalmology, Tan Tock Seng Hospital, Singapore
Pages 232-237 | Received 06 Sep 2015, Accepted 15 Feb 2016, Published online: 24 Jun 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Justus G Garweg. (2019) Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration. Clinical Ophthalmology 13, pages 1289-1295.
Read now
Decai Wang, Yu Jiang, Miao He, Jane Scheetz & Wei Wang. (2019) Disparities in the Global Burden of Age-Related Macular Degeneration: An Analysis of Trends from 1990 to 2015. Current Eye Research 44:6, pages 657-663.
Read now
Asitha Balachandra, Elsa C. Chan, Joseph P. Paul, Sze Ng, Vicki Chrysostomou, Steven Ngo, Roshan Mayadunne & Peter van Wijngaarden. (2019) A biocompatible reverse thermoresponsive polymer for ocular drug delivery. Drug Delivery 26:1, pages 343-353.
Read now

Articles from other publishers (7)

Kevin Y. Wu, Jamie K. Fujioka, Tara Gholamian, Marian Zaharia & Simon D. Tran. (2023) Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery. Pharmaceuticals 16:9, pages 1241.
Crossref
Yuki Hama, Manabu Miyata, Sotaro Ooto, Hiroshi Tamura, Naoko Ueda-Arakawa, Yuki Muraoka, Masahiro Miyake, Ayako Takahashi, Tomotaka Wakazono, Akihito Uji, Kenji Yamashiro & Akitaka Tsujikawa. (2023) Seven-year outcome after 1-year fixed regimen of intravitreal aflibercept injections followed by pro re nata treatment for neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 261:7, pages 1871-1881.
Crossref
Ana Patricia Marques, Jacqueline Ramke, John Cairns, Thomas Butt, Justine H. Zhang, Iain Jones, Marty Jovic, Allyala Nandakumar, Hannah Faal, Hugh Taylor, Andrew Bastawrous, Tasanee Braithwaite, Serge Resnikoff, Peng T. Khaw, Rupert Bourne, Iris Gordon, Kevin Frick & Matthew J. Burton. (2022) The economics of vision impairment and its leading causes: A systematic review. eClinicalMedicine 46, pages 101354.
Crossref
Li Lian Foo, Carla Lanca, Chee Wai Wong, Daniel Ting, Ecosse Lamoureux, Seang-Mei Saw & Marcus Ang. (2021) Cost of Myopia Correction: A Systematic Review. Frontiers in Medicine 8.
Crossref
Yamin Li, Lina Liang, Torkel Snellingen, Kai Xu, Yun Gao, Fengmei Zhang, Chengwei Guo, Tao Zuo, Fengming Liang, Xiaoping Yao & Xueyan Yang. (2021) Mingjing granule, a traditional Chinese medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trial. Trials 22:1.
Crossref
Maarten P. Rozing, Jon A. Durhuus, Marie Krogh Nielsen, Yousif Subhi, Thomas BL. Kirkwood, Rudi GJ. Westendorp & Torben Lykke Sørensen. (2020) Age-related macular degeneration: A two-level model hypothesis. Progress in Retinal and Eye Research 76, pages 100825.
Crossref
Seung Kook Baek, Jae Hui Kim, Jong Woo Kim & Chul Gu Kim. (2019) Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment. Scientific Reports 9:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.